The Evolving Landscape in the Development of Isocitrate Dehydrogenase Mutant Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|16|16|1344-1358

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.16, Iss.16, 2016-09, pp. : 1344-1358

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modulation of NADP+-dependent isocitrate dehydrogenase in aging

By Kil In Sup   Lee Young Sup   Bae Young Seuk   Huh Tae Lin   Park Jeen-Woo  

Redox Report, Vol. 9, Iss. 5, 2004-10 ,pp. : 271-277

Maney Publishing

Access to resources Recommend Favorite

Inhibition of Mutated Isocitrate Dehydrogenase 1 in Cancer

By  

Medicinal Chemistry, Vol. 14, Iss. 7, 2018-11 ,pp. : 715-724

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Mycobacterial Isocitrate Lyase Targeting and Inhibitors

By  

Current Medicinal Chemistry, Vol. 19, Iss. 36, 2012-12 ,pp. : 6126-6137

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of dihydroorotate dehydrogenase

By Batt D.G.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 1, 1999-01 ,pp. : 41-54

Informa Healthcare

Access to resources Recommend Favorite

11&bgr;-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development

By  

Current Medicinal Chemistry, Vol. 17, Iss. 5, 2010-02 ,pp. : 412-422

Bentham Science Publishers

Access to resources Recommend Favorite